In Treatment of Respiratory tract infection Respiratory tract infections are those infections that can affect the sinuses, throat, airways or lungs. K-Cefod-CV Tablet contains two different medicines, Cefpodoxime Proxetil and Clavulanic Acid, that work together to kill the bacteria that cause respiratory tract infections. Cefpodoxime Proxetil works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is not known whether it is safe to consume alcohol with K
CV Tablet. Please consult your doctor.
K
CV Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
K
CV Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
K
CV Tablet may cause side effects which could affect your ability to drive. K
CV Tablet may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
K
CV Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of K
CV Tablet may be needed. Please consult your doctor.
There is limited information available on the use of K
CV Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of K-Cefod-CV Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Nidus Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Endocard India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ethics Health Care Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Swakam Biotech Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanoti Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Osiante Biotech || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pfizer Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Niyamba Pharmaceutical Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medifaith Biotech || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mosfet Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)